Register to receive a free US Market for ENT and Bronchoscopic Devices Report Suite synopsis and brochure
BIOCORP, a French company specializing in the development and manufacturing of medical devices and smart drug delivery systems, recently announced the launch of Inspair, the smart sensor which converts inhalers into connected devices to help patients with Asthma or COPD.
“Biocorp’s objective is to develop innovative solutions in order to improve treatment compliance by patients suffering from chronic diseases. Significant applications have been developed in diabetology, endocrinology and neurology with the Datapen and Easylog devices, and our new sensor Inspair also positions us in the area of chronic lung diseases which affect an increasing number of people in need of new solutions to improve compliance”, said Jacques Gardette, Biocorp’s Founder and CEO
Asthma is a chronic disease which affects the respiratory tracts: it is characterized by an inflammation and irritation of the bronchial tubes which overreact to various triggers, and causes attacks with typical identifiable symptoms: difficulty in breathing, shortness of breath, dry cough or wheezing.
Asthma is a disease lived by 4 million people in France and 334 million in the world1, and which can rapidly affect the patients’ daily lives if it is not carefully controlled. The compliance and monitoring of the disease are all the more necessary in that a poor management of asthma can rapidly lead to severe asthma responsible for more than 500,000 emergency hospitalization and 1,000 to 1,500 deaths every year in France. The French health insurance estimates that nearly six in ten people with asthma have inadequate control of their disease and treatment.
COPD is a chronic lung disease which develops slowly and is characterized by an airway obstruction. It is different from Asthma and usually affects older people suffering from prolonged intoxication, mostly because of smoking (90%). COPD affects about 3 million people in France, and is responsible for more deaths than HIV or Influenza. A fastidious treatment follow-up with inhaler and/or bronchodilator medication is thus required to reduce symptoms and improve the patient’s quality of life.
Inspair brings an innovative and effective response to the needs of these two pathologies: it acts directly on the treatment compliance and also strengthens the connection between the patient and the medical staff who can provide a real-time therapeutic follow-up. Inspair is a smart sensor capable of converting any pressurized metered dose inhaler into a connected device: it is then able to record data related to the inhalations and to assure an optimal management of the treatment (mastering of the inhalation technique). Equipped with miniaturized sensors and electronic card, Inspair fits on most MDI mouthpieces on the market using specific adaptors. The system automatically records data related to daily inhalations, ensures the right preparation of the canister (shake before usage), assesses the coordination of actuation with inhalation (“hand-mouth” coordination) and also provides with useful guidance throughout the inhalation steps.
Inspair acts on the key levers of the integrated therapeutic education which lowers hospital admissions and calls to emergency services, reduces the frequency of the attacks and other symptoms, and improves the patient’s daily comfort. More than a simple tool for treatment, Biocorp’s connected device becomes an integral part of it.
Still following its Intellectual Property strategy, providing the company with a key competitive advantage, Biocorp has deposited a series of international patents that ensure its full ownership, proof of anteriority and exclusive rights over the exploitation of Inspair.
For Further Information
More on the bronchial device market in the US can be found in a report suite published by iData Research entitled the US Market for ENT and Bronchoscopic Devices Report Suite. The suite covers reports on the following markets: ENT Endoscopes, ENT Powered Instruments, ENT Hand Instruments, ENT Radiofrequency Devices, Balloon Sinus Dilation Devices, Bronchoscopes, Bronchoscope Hand Instruments, Bronchial Stents, Bronchial Forceps, Transbronchial Aspiration Needles, and Foreign Body Removal Devices.
Reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about ENT and Bronchoscopic device market data or procedure data, register online or email us at [email protected] for a US Market for ENT and Bronchoscopic Devices Report Suite report series brochure and synopsis.
About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Dental Operatory Equipment, X-Ray Imaging, Vascular Access, Peripheral Vascular, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Diagnostic Imaging, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Oncology, Ultrasound, Laparoscopy, Urology, Gynecology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large and Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics and more.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.